This inventor holds 1 USPTO granted patent and 9 published patent applications, plus 1 CIPO patent. Top assignee: Vivus, Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Calvin Theodore Broman: Innovator in Pharmaceutical Formulations
Introduction
Calvin Theodore Broman is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the delivery and absorption of active pharmaceutical ingredients.
Latest Patents
Calvin Broman holds a patent for an "Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use." This invention provides formulations for the oral administration of avanafil, a Type V phosphodiesterase inhibitor. The orally disintegrating tablets (ODTs) are designed to rapidly dissolve in the oral cavity, enhancing the absorption of the active agent in the duodenum. The patent also outlines methods for manufacturing these tablets to optimize their physical properties, such as hardness and disintegration time.
Career Highlights
Calvin Broman is currently associated with Vivus, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in formulation science has contributed to advancements in drug delivery systems.
Collaborations
Calvin collaborates with Eric Sheu, working together to push the boundaries of pharmaceutical innovations. Their combined efforts aim to improve patient outcomes through effective drug formulations.
Conclusion
Calvin Theodore Broman's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his role as a key inventor in enhancing drug delivery systems. His work continues to impact the industry positively.